Relapse of skin thickening after discontinuation or decrease of azathioprine therapy in a patient with diffuse cutaneous systemic sclerosis.
Scheja
A
A
Department of Rheumatology, Lund University Hospital, S-221 85, Lund, Sweden. agneta.scheja@med.lu.se
Hesselstrand
R
R
Wildt
M
M
Akesson
A
A
D000368:Aged; D001379:Azathioprine / Q000008:administration & dosage*; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D012008:Recurrence; D018570:Risk Assessment; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index; D012867:Skin / Q000473:pathology*; D013997:Time Factors
D007166:Immunosuppressive Agents; D001379:Azathioprine